Clinical trial
Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus…
NCT00047580 · Elan Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00047580 |
|---|---|
| Title | Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity. |
| Official title | A Multicenter, Open-Label, Randomized, 4-Way Crossover Trial of the Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex (Tizanidine Hydrochloride) Tablets Taken Under Fed and Fasted Conditions in Patients With Moderate to Severe Spasticity |
| Lead sponsor | Elan Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis, Muscle Spasticity, Spinal Cord Injury, Stroke |
| Intervention type | Drug |
| Interventions | tizanidine hydrochloride capsule |
| Enrollment | 120 |
| Start date | Jun 1, 2002 |
| Completion | Sep 1, 2002 |
| First posted | Oct 10, 2002 |
| Last update posted | Dec 14, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: